Ryan Joseph Horvath, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microglia | 4 | 2010 | 1248 | 0.620 |
Why?
|
| Morphine | 2 | 2010 | 655 | 0.520 |
Why?
|
| Receptors, Purinergic P2X4 | 2 | 2010 | 22 | 0.460 |
Why?
|
| Calcium-Binding Proteins | 3 | 2010 | 1078 | 0.380 |
Why?
|
| Receptors, Opioid | 1 | 2010 | 155 | 0.360 |
Why?
|
| Drug Tolerance | 1 | 2010 | 376 | 0.330 |
Why?
|
| Cell Movement | 3 | 2009 | 5220 | 0.320 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2009 | 151 | 0.310 |
Why?
|
| Narcotics | 1 | 2009 | 343 | 0.280 |
Why?
|
| Electroconvulsive Therapy | 2 | 2021 | 469 | 0.270 |
Why?
|
| Lipopolysaccharides | 1 | 2008 | 2208 | 0.190 |
Why?
|
| Microfilament Proteins | 3 | 2010 | 1150 | 0.170 |
Why?
|
| Nitric Oxide | 1 | 2008 | 2121 | 0.170 |
Why?
|
| Aerosols | 1 | 2020 | 619 | 0.150 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2020 | 363 | 0.150 |
Why?
|
| Naloxone | 2 | 2010 | 367 | 0.150 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2009 | 625 | 0.140 |
Why?
|
| Anesthetics | 1 | 2021 | 536 | 0.130 |
Why?
|
| Narcotic Antagonists | 2 | 2010 | 562 | 0.130 |
Why?
|
| Gene Expression Regulation | 2 | 2010 | 12064 | 0.130 |
Why?
|
| Clinical Protocols | 1 | 2020 | 1453 | 0.120 |
Why?
|
| Cytokines | 1 | 2008 | 7296 | 0.110 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 1 | 2010 | 57 | 0.090 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2010 | 8292 | 0.090 |
Why?
|
| Rats | 4 | 2010 | 24259 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase Phosphatases | 1 | 2009 | 47 | 0.090 |
Why?
|
| Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 1 | 2009 | 36 | 0.090 |
Why?
|
| Receptor, Cannabinoid, CB2 | 1 | 2009 | 49 | 0.090 |
Why?
|
| Benzeneacetamides | 1 | 2009 | 39 | 0.080 |
Why?
|
| Respiration, Artificial | 1 | 2020 | 2560 | 0.080 |
Why?
|
| Signal Transduction | 2 | 2010 | 23355 | 0.080 |
Why?
|
| Pyridoxal Phosphate | 1 | 2009 | 127 | 0.080 |
Why?
|
| Anesthesia | 1 | 2020 | 1543 | 0.080 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2010 | 526 | 0.080 |
Why?
|
| Receptors, Epoprostenol | 1 | 2008 | 12 | 0.080 |
Why?
|
| Purinergic P2 Receptor Antagonists | 1 | 2009 | 71 | 0.080 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2010 | 293 | 0.080 |
Why?
|
| Xanthines | 1 | 2008 | 121 | 0.080 |
Why?
|
| Adenosine Diphosphate | 1 | 2009 | 425 | 0.080 |
Why?
|
| Minocycline | 1 | 2008 | 163 | 0.080 |
Why?
|
| Pyrrolidines | 1 | 2009 | 341 | 0.070 |
Why?
|
| Animals, Newborn | 2 | 2009 | 2733 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2009 | 10939 | 0.070 |
Why?
|
| Hyperalgesia | 1 | 2010 | 500 | 0.070 |
Why?
|
| Tunica Intima | 1 | 2008 | 464 | 0.070 |
Why?
|
| Random Allocation | 1 | 2010 | 2417 | 0.070 |
Why?
|
| Drug Interactions | 1 | 2010 | 1456 | 0.070 |
Why?
|
| Time Factors | 3 | 2010 | 40040 | 0.060 |
Why?
|
| Neuroglia | 1 | 2008 | 928 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2009 | 19223 | 0.050 |
Why?
|
| Adenosine Triphosphate | 1 | 2009 | 2022 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3143 | 0.050 |
Why?
|
| Behavior, Animal | 1 | 2010 | 1891 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3248 | 0.050 |
Why?
|
| Spinal Cord | 1 | 2010 | 1818 | 0.050 |
Why?
|
| Neuroprotective Agents | 1 | 2008 | 940 | 0.050 |
Why?
|
| Thiopental | 1 | 2021 | 59 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2010 | 6364 | 0.050 |
Why?
|
| Analgesics | 1 | 2008 | 1034 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 3863 | 0.050 |
Why?
|
| Receptors, Cell Surface | 1 | 2010 | 2865 | 0.050 |
Why?
|
| Pain Measurement | 1 | 2010 | 3419 | 0.050 |
Why?
|
| Pandemics | 1 | 2020 | 8274 | 0.050 |
Why?
|
| Antigens, CD | 1 | 2010 | 4024 | 0.040 |
Why?
|
| Venous Thrombosis | 1 | 2008 | 1232 | 0.040 |
Why?
|
| Anesthetics, Intravenous | 1 | 2021 | 417 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2009 | 3800 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2010 | 4464 | 0.040 |
Why?
|
| Animals | 5 | 2010 | 168358 | 0.030 |
Why?
|
| Pain | 1 | 2008 | 4923 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 2008 | 5717 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2010 | 18002 | 0.020 |
Why?
|
| Dual Specificity Phosphatase 6 | 1 | 2009 | 13 | 0.020 |
Why?
|
| Dual Specificity Phosphatase 1 | 1 | 2009 | 44 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2008 | 15500 | 0.020 |
Why?
|
| Seizures | 1 | 2021 | 2829 | 0.020 |
Why?
|
| Thromboxane B2 | 1 | 2008 | 152 | 0.020 |
Why?
|
| Electroencephalography | 1 | 2021 | 6133 | 0.020 |
Why?
|
| Cannabinoids | 1 | 2008 | 167 | 0.020 |
Why?
|
| P-Selectin | 1 | 2008 | 600 | 0.020 |
Why?
|
| Hyperplasia | 1 | 2008 | 1181 | 0.020 |
Why?
|
| Platelet Activation | 1 | 2008 | 670 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2009 | 1212 | 0.020 |
Why?
|
| Genetic Linkage | 1 | 2008 | 2433 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2020 | 12655 | 0.010 |
Why?
|
| Mice | 1 | 2008 | 80995 | 0.010 |
Why?
|
| Male | 3 | 2020 | 348967 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2009 | 4205 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2009 | 8414 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2008 | 3441 | 0.010 |
Why?
|
| Analgesics, Opioid | 1 | 2008 | 3649 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2020 | 76632 | 0.010 |
Why?
|
| Phenotype | 1 | 2009 | 16300 | 0.010 |
Why?
|
| Humans | 4 | 2021 | 739219 | 0.010 |
Why?
|
| Adult | 2 | 2020 | 213375 | 0.010 |
Why?
|
| Inflammation | 1 | 2009 | 10531 | 0.010 |
Why?
|
| Female | 2 | 2020 | 378808 | 0.000 |
Why?
|
| Aged | 1 | 2008 | 162667 | 0.000 |
Why?
|
| Middle Aged | 1 | 2008 | 212833 | 0.000 |
Why?
|